Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol combined with low-dose esketamine for prevention of postoperative pulmonary complications after video-assisted thoracic surgery
ChiCTR2600134784Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jul 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol and esketamine in postoperative respiratory complications (PRC) and postoperative pain (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Postoperative pulmonary complications within 7 days after surgery. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ciprofolesketamine
03
Conditions
postoperative respiratory complications (PRC)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600134784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134784.